These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18716801)

  • 21. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population.
    Chen L; Zhang S; Liu Y; Hong H; Wang H; Zheng Y; Zhou H; Chen J; Xian W; He Y; Li J; Liu Z; Pei Z; Zeng J
    Parkinsonism Relat Disord; 2011 May; 17(4):291-2. PubMed ID: 21159540
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
    Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
    Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
    Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
    PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association of DNM3 with age of onset in Asian Parkinson's disease.
    Foo JN; Tan LC; Au WL; Prakash KM; Liu J; Tan EK
    Eur J Neurol; 2019 May; 26(5):827-829. PubMed ID: 30133089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of LRRK2 A419V variant in ethnic Chinese.
    Li NN; Tan EK; Chang XL; Mao XY; Zhang JH; Zhao DM; Liao Q; Peng R
    Neurobiol Aging; 2012 Aug; 33(8):1849.e1-3. PubMed ID: 22418733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.
    Skipper L; Li Y; Bonnard C; Pavanni R; Yih Y; Chua E; Sung WK; Tan L; Wong MC; Tan EK; Liu J
    Hum Mol Genet; 2005 Dec; 14(23):3549-56. PubMed ID: 16269443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.
    Yan H; Ma Q; Yang X; Wang Y; Yao Y; Li H
    Mol Med Rep; 2012 Oct; 6(4):879-83. PubMed ID: 22842796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients.
    Chen H; Yuan L; Song Z; Deng X; Yang Z; Gong L; Zi X; Deng H
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):398-402. PubMed ID: 29812962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
    Pulkes T; Papsing C; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1018-21. PubMed ID: 24997548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 P755L variant in sporadic Parkinson's disease.
    Tomiyama H; Mizuta I; Li Y; Funayama M; Yoshino H; Li L; Murata M; Yamamoto M; Kubo SI; Mizuno Y; Toda T; Hattori N
    J Hum Genet; 2008; 53(11-12):1012-1015. PubMed ID: 18923807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
    Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
    Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
    [No Abstract]   [Full Text] [Related]  

  • 37. LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.
    Bonifati V
    Neurochem Res; 2007 Oct; 32(10):1700-8. PubMed ID: 17440812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
    Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
    Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.
    Mata IF; Hutter CM; González-Fernández MC; de Pancorbo MM; Lezcano E; Huerta C; Blazquez M; Ribacoba R; Guisasola LM; Salvador C; Gómez-Esteban JC; Zarranz JJ; Infante J; Jankovic J; Deng H; Edwards KL; Alvarez V; Zabetian CP
    Neurogenetics; 2009 Oct; 10(4):347-53. PubMed ID: 19308469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.